Company Quick10K Filing
Seneca Foods
10-Q 2020-12-26 Filed 2021-02-03
10-Q 2020-09-26 Filed 2020-11-04
10-Q 2020-06-27 Filed 2020-08-05
10-K 2020-03-31 Filed 2020-07-02
10-Q 2019-12-28 Filed 2020-02-05
10-Q 2019-09-28 Filed 2019-11-06
10-Q 2019-06-29 Filed 2019-08-07
10-K 2019-03-31 Filed 2019-06-13
10-Q 2018-12-29 Filed 2019-02-01
10-Q 2018-09-29 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-07-31
10-K 2018-03-31 Filed 2018-06-29
10-Q 2017-12-30 Filed 2018-01-25
10-Q 2017-09-30 Filed 2017-10-26
10-Q 2017-07-01 Filed 2017-07-31
10-K 2017-03-31 Filed 2017-05-25
10-Q 2016-12-31 Filed 2017-01-25
10-Q 2016-10-01 Filed 2016-11-07
10-Q 2016-07-02 Filed 2016-07-29
10-K 2016-03-31 Filed 2016-06-08
10-Q 2015-12-26 Filed 2016-02-02
10-Q 2015-09-26 Filed 2015-11-02
10-Q 2015-06-27 Filed 2015-07-31
10-K 2015-03-31 Filed 2015-06-09
10-Q 2014-12-27 Filed 2015-02-02
10-Q 2014-09-27 Filed 2014-10-23
10-Q 2014-06-28 Filed 2014-08-06
10-K 2014-03-31 Filed 2014-05-22
10-Q 2013-12-28 Filed 2014-01-29
10-Q 2013-09-28 Filed 2013-10-23
10-Q 2013-06-29 Filed 2013-08-01
10-K 2013-03-31 Filed 2013-05-23
10-Q 2012-12-29 Filed 2013-01-31
10-Q 2012-09-29 Filed 2012-10-25
10-Q 2012-06-30 Filed 2012-08-03
10-K 2012-03-31 Filed 2012-06-08
10-Q 2011-12-31 Filed 2012-01-27
10-Q 2011-10-01 Filed 2011-10-27
10-Q 2011-07-02 Filed 2011-08-03
10-K 2011-03-31 Filed 2011-05-26
10-Q 2011-01-01 Filed 2011-01-27
10-Q 2010-10-02 Filed 2010-10-28
10-Q 2010-07-03 Filed 2010-08-04
10-K 2010-03-31 Filed 2010-05-26
10-Q 2009-12-26 Filed 2010-02-02
8-K 2020-11-04
8-K 2020-11-04
8-K 2020-10-27
8-K 2020-09-15
8-K 2020-08-31
8-K 2020-08-18
8-K 2020-08-05
8-K 2020-06-12
8-K 2020-05-28
8-K 2020-03-31
8-K 2020-02-05
8-K 2019-11-06
8-K 2019-08-22
8-K 2019-08-07
8-K 2019-08-07
8-K 2019-06-13
8-K 2019-05-09
8-K 2018-12-29
8-K 2018-12-07
8-K 2018-11-09
8-K 2018-08-10
8-K 2018-07-31
8-K 2018-07-27
8-K 2018-06-29
8-K 2018-06-28
8-K 2018-02-16
8-K 2018-01-25

Seneca Foods Financials

SENEA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
1347 Capital Corp (TFSC)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
Ameren Illinois Co (AILNP)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-07-022011-10-012011-12-312012-03-312012-06-302012-09-292012-12-292013-03-312013-06-292013-09-282013-12-282014-03-312014-06-282014-09-272014-12-272015-03-312015-06-272015-09-262015-12-262016-03-312016-07-022016-10-012016-12-312017-03-312017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-292019-03-312019-06-292019-09-28
Cash91011912191314618181411142311891991210101216151315131313111718
Accounts Receivable618475775684708353967377538172705483757766103677279112667989100838474116
Inventory432733538432458727528480485759551451467732547472483762631568587772656598634802710681569684576502493575
PP&E188186185522197190186536187185182548188189186569182178190587193207218657270272272719272242246638206205
Assets7221,0538377387391,0478238037771,1118677697741,0658818067791,0889608959201,1491,0059461,0071,2101,0721,0709641,1229628499251,046
Accounts Payable82279906110428198729029911871882441036886266996710323798731102501027098212946178196
Long-Term Debt211331298234188319270274233326270220224346298275239345349316308363352333343399415418331354325266247244
Liabilities376704470383376698459436408737485375388681489454425728570490515738587512573780635674562712542431511633
Stockholders' Equity346349367355362350364367368375381394386384392352354360390405405410418434433430437397402410420417414413
Income Statement ($MM)2011-07-022011-10-012011-12-312012-03-312012-06-302012-09-292012-12-292013-03-312013-06-292013-09-282013-12-282014-03-312014-06-282014-09-272014-12-272015-03-312015-06-272015-09-262015-12-262016-03-312016-07-022016-10-012016-12-312017-03-312017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-292019-03-312019-06-292019-09-28
Revenue259284448271231318453275232337478294240312456278226313432304253357370266280376393343321372263265370
Cost of Revenue337310374249246346
Gross Profit611-2141924
R&D
SG&A16151917151619191616201816161917151720221719211617192017181819171618
Tax-4111-259721-1220-02223156-0341-2-1-0-4-3-2-7-301
Net Income-8319-2815154177-1-0-183373114-068-2-1-18-20-9914-915
Cash Flow ($MM)2011-07-022011-10-012011-12-312012-03-312012-06-302012-09-292012-12-292013-03-312013-06-292013-09-282013-12-282014-03-312014-06-282014-09-272014-12-272015-03-312015-06-272015-09-262015-12-262016-03-312016-07-022016-10-012016-12-312017-03-312017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-292019-03-312019-06-292019-09-28
Cash Operating31-117379059-105463235-82604533-110583846-1035220-48193420-91487-20513827
Cash Investing-5-4-4-24-108-2-7-3-4-4-7-26-7-3-7-2-1-18-6-8-9-8-21-7-11-0-012-3-3
Cash Financing-22122-32-68-46104-50-23-3998-57-42-10120-47-43-47105-44-954-10-24514-0-8921-65-29-23